DK0639640T3 - Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 - Google Patents

Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91

Info

Publication number
DK0639640T3
DK0639640T3 DK94305561T DK94305561T DK0639640T3 DK 0639640 T3 DK0639640 T3 DK 0639640T3 DK 94305561 T DK94305561 T DK 94305561T DK 94305561 T DK94305561 T DK 94305561T DK 0639640 T3 DK0639640 T3 DK 0639640T3
Authority
DK
Denmark
Prior art keywords
infectious bronchitis
bronchitis virus
vaccine containing
virus serotype
containing infectious
Prior art date
Application number
DK94305561T
Other languages
Danish (da)
English (en)
Inventor
Jane Kathleen Alexandra Cook
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0639640T3 publication Critical patent/DK0639640T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/816Viral vaccine for avian species, e.g. poultry or other birds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK94305561T 1993-07-30 1994-07-27 Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 DK0639640T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93306033 1993-07-30

Publications (1)

Publication Number Publication Date
DK0639640T3 true DK0639640T3 (da) 2001-01-02

Family

ID=8214489

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94305561T DK0639640T3 (da) 1993-07-30 1994-07-27 Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91

Country Status (9)

Country Link
US (2) US5750113A (de)
EP (1) EP0639640B1 (de)
JP (1) JP3650634B2 (de)
AT (1) ATE196773T1 (de)
DE (1) DE69426051T2 (de)
DK (1) DK0639640T3 (de)
ES (1) ES2152292T3 (de)
GR (1) GR3035135T3 (de)
PT (1) PT639640E (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
US20010046500A1 (en) * 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
DK1259257T3 (da) * 2000-02-29 2010-06-14 Wyeth Llc In-ovo beskyttelse mod infektiøs bronchitis
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US6605460B1 (en) 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
JP4373916B2 (ja) * 2002-09-18 2009-11-25 インターベツト・インターナシヨナル・ベー・ベー ニワトリ2型アストロウイルス
US6605283B1 (en) 2002-11-01 2003-08-12 The United States Of America As Represented By The Secretary Of Agriculture Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
US7291342B2 (en) * 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine
JP5100122B2 (ja) 2003-10-31 2012-12-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 細菌の病原因子とそれらの使用
BRPI0417880A (pt) * 2003-12-23 2007-04-27 Intervet Int Bv vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
RU2474587C2 (ru) 2007-06-08 2013-02-10 Острэйлиан Паултри Срс Пти Лтд КЛОСТРИДИАЛЬНЫЙ ТОКСИН NetB
JP4935761B2 (ja) * 2008-06-02 2012-05-23 株式会社微生物化学研究所 家禽大腸菌症ワクチン
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
KR101092977B1 (ko) 2009-03-09 2011-12-26 대한민국 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신
CN108653724B (zh) * 2017-04-01 2020-11-27 普莱柯生物工程股份有限公司 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用
CN112996537A (zh) * 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN109628412B (zh) * 2018-12-27 2021-11-02 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) 一株鸡传染性支气管炎病毒毒株及其应用
CN112048006B (zh) * 2020-09-08 2021-04-27 扬州大学 一种替代中和效力测定的elisa方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801M (fr) * 1963-05-20 1964-09-21 Pierre Lepine Vaccins dits interférentiels contre les maladies a virus.
US4357320A (en) * 1980-11-24 1982-11-02 Gist-Brocades N. V. Infectious bronchitis vaccine for poultry
USRE31830E (en) * 1979-11-13 1985-02-12 Gist-Brocades N.V. Infectious bronchitis vaccine for poultry
USRE34013E (en) * 1979-11-30 1992-07-28 Gist-Brocades N.V. Infectious bronchitis vaccine for poultry
US4500638A (en) * 1979-11-30 1985-02-19 Gist-Brocades N.V. Infectious bronchitis virus strain
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines
USRE32423E (en) * 1979-11-30 1987-05-19 Gist-Brocades N.V. Infectious bronchitis virus strain
EP0073856A1 (de) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Impfstoff gegen ansteckende Bronchitis bei Geflügel, kombinierte Impfstoffe gegen ansteckende Bronchitis, Verfahren zu deren Herstellung, Verfahren zur Vorbeugung der ansteckenden Bronchitis und Virenstamm der ansteckenden Bronchitis
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
GB8431253D0 (en) * 1984-12-11 1985-01-23 Glaxo Group Ltd Biological preparations
EP0218625B1 (de) * 1985-03-29 1995-04-05 Btg International Limited Spike-protein des virus der infektiösen bronchitis
DE3681229D1 (de) * 1985-07-18 1991-10-10 Duphar Int Res Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff

Also Published As

Publication number Publication date
US5750113A (en) 1998-05-12
ATE196773T1 (de) 2000-10-15
JPH07147974A (ja) 1995-06-13
US6086892A (en) 2000-07-11
PT639640E (pt) 2001-03-30
DE69426051D1 (de) 2000-11-09
JP3650634B2 (ja) 2005-05-25
ES2152292T3 (es) 2001-02-01
EP0639640A1 (de) 1995-02-22
DE69426051T2 (de) 2001-05-10
GR3035135T3 (en) 2001-04-30
EP0639640B1 (de) 2000-10-04

Similar Documents

Publication Publication Date Title
ATE196773T1 (de) Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
DE69632235D1 (de) Newcastle-Krankheitsvirus-Kombinationsimpfstoff
PL304419A1 (en) Urease based vaccine against heliobacter infections
NZ192477A (en) Method for protecting dogs against virulent canine parvovirus using inactivated virus vaccine
MY103575A (en) Cannie coronavirus vaccine
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
TW340873B (en) Chicken anaemia agent vaccine
ES8403319A1 (es) Nuevas vacunas contra la bronquitis infecciosa.
ATE392429T1 (de) Lebend-impfstoff gegen heliobacter pylori
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
DK0510996T3 (da) Rekombinant varicella-zoster virus vektor
AU3115189A (en) Live combination vaccine
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
PL346195A1 (en) Chicken anaemia virus (cav) of weakened patogenicity, vaccine for protecting poultry against cav and method of obtaining cav of weakened pathogenicity
NZ243251A (en) Vaccine against marek's disease virus in poultry